S-RALP(N = 151) | L-RALP(N = 126) | P value | |
---|---|---|---|
Age (year), mean ± SD | 67.00 ± 5.54 | 66.24 ± 6.22 | 0.282 |
BMI (kg/m2), mean ± SD | 23.77 ± 2.99 | 23.87 ± 3.13 | 0.779 |
PSA (ng/ml), mean ± SD | 9.47 ± 3.58 | 9.63 ± 3.59 | 0.722 |
MRI PIRADS score, mean ± SD | 4.09 ± 0.52 | 3.96 ± 0.65 | 0.061 |
TNM stage no. (%) | |||
T2a | 18(11.9%) | 14(11.1%) | 0.873 |
T2b | 94(62.3%) | 76(60.3%) | |
T2c | 39(25.8%) | 36(28.6%) | |
Gleason score no. (%) | |||
6 | 51(33.8%) | 49(38.9%) | 0.378 |
7 | 100(66.2%) | 77(61.1%) | |
Baseline EPIC-CP urinary incontinence score, mean ± SD | 1.19 ± 0.96 | 1.37 ± 0.94 | 0.053 |
Baseline EPIC-CP sexual function score, mean ± SD | 2.99 ± 1.26 | 3.19 ± 1.34 | 0.111 |
Baseline EPIC-CP total score, mean ± SD | 8.13 ± 4.26 | 8.19 ± 2.07 | 0.760 |